Anova Biomedical is developing synthetic bioresorbable grafts to enable long-term, incident-free hemodialysis. The technology originated in Professor Yadong Wang’s lab and is spun out thanks to the Ignite Fellow for New Venture program, a startup accelerator from Cornell.
